Quality of life analysis of Pemetrexed versus Erlotinib maintenance in EGFR mutation negative advanced non small cell lung cancer.

Authors

Vivek Agarwala

Vivek Agarwala

Tata Memorial Centre, Mumbai, India

Vivek Agarwala , Vijay Maruti Patil , Vanita Noronha , Amit Joshi , Anuradha Chougule , Vaishakhi Trivedi , Rajiv Kumar , Sucheta More , Supriya Goud , Amit Janu , Abhishek Mahajan , Kumar Prabhash

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

CTRI/2014/08/004847

Citation

J Clin Oncol 36, 2018 (suppl; abstr 9024)

DOI

10.1200/JCO.2018.36.15_suppl.9024

Abstract #

9024

Poster Bd #

347

Abstract Disclosures